Trevena, Inc (TRVN) - Net Sales Margin

Public company logo of Trevena Inc. (TRVN)

Trevena, Inc. (TRVN) is developing unique therapies, creating a sovereign product cycle independent of macroeconomic trends. The net profit margin reflects this progress, where 0.00 characterizes this valuation parameter. Stability is ensured by the constant, non-cyclical demand for hospital analgesics. The business foundation consists of top-tier neuropharmacologists motivated by stock options tied to FDA milestones.

TRVN: trevena.com Company Sales Margin 07/04/2022 - 10/19/2024

Trevena, Inc. (TRVN) - metric breakdowns and financial figures

- market value and analyst target forecast:
Fundamental valuation:Trevena, Inc.
Manufactured product of Trevena Inc

Sales margins determine the share of net profit in every dollar of revenue, characterizing the overall efficiency of the business. This metric is calculated as the ratio of the final financial result to total income, demonstrating sensitivity to operating expenses. Analyzing the level of net profitability of sales allows for an assessment of the company's resilience to market fluctuations. For Trevena, Inc. (TRVN), this metric reflects the costs of bringing Olinvyk to the analgesic market. High investments in the development of opioid alternatives are temporarily suppressing profitability.

Key competitors

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Net Sales Margin|AXSM: Net Profit Rate|Net Margin acadia-pharm.com (ACAD)|Net Sales Margin Xenon Pharmaceuticals (XENE)|Net Margin Viking Therapeutics VKTX|Net Profit Rate SUPN|CPRX - Net Margin|Net Margin Denali Therapeutics|HRMY: Net Sales Margin|Biohaven - Net Profit Rate|Return on Sales by Net Profit AMLX|Trevi Therapeutics, Inc. (TRVI) - Company Sales Margin|Return on Sales by Net Profit PRAX (Praxis Medicines)|Anavex Corp - Net Return on Sales|Net Margin CeriBell CBLL|Company Sales Margin Prothena Biosciences (PRTA)|ALEC: Return on Sales by Net Profit|ANNX - Net Sales Margin|Omeros Corp. (OMER) - Net Margin|Net Margin Neurogene Inc. (NGNE)|Return on Sales by Net Profit ACIU|Net Margin VYGR|Net Margin Neumora (NMRA)|SCLX - Net Margin|Net Sales Margin TVGN (Tevogen Bio Holdings Inc.)|Net Profit Rate ACOG|Cognition Therapeutics Inc. - Net Sales Margin|IKT - Net Sales Margin|SAVA: Net Sales Margin|Assertio Holdings, Inc. - Net Profit Rate|COYA (Coya) - Net Sales Margin|Net Return on Sales VTGN (Vistagen Therapeutics)|Net Margin Ovid Rx (OVID)|Acumen Pharmaceuticals - Net Return on Sales|Net Margin CervoMed, Inc. CRVO|Net Sales Margin Alterity Therapeutics ATHE|CLNN: Return on Sales by Net Profit|PEPG (pepgen.com) - Net Return on Sales|Jupiter Neurosciences Inc (JUNS) - Net Margin|Relmada Therapeutics - Net Profit Rate|ANVS (Annovis Bio Inc) - Net Sales Margin|GRCE: Net Profit Rate|Net Margin Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Net Profit Rate|Net Margin neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Net Margin|MTVA: Return on Sales by Net Profit|NeurAxis, Inc (NRXS) - Return on Sales by Net Profit|HSDT: Net Sales Margin|PASG - Company Sales Margin|Net Margin Neuphoria Therapeutics, Inc.|Net Margin NERV|Net Sales Margin ATHA|ADXN (Addex Therapeutics Ltd) - Net Profit Rate|Net Margin alzamend.com ALZN|Company Sales Margin Cyclerion Therapeutics (CYCN)|Protagenic - Net Sales Margin|Net Profit Rate KTTA (Pasithea Therapeutics Corp)|CRGT: Net Sales Margin|Avenue Therapeutics Inc. (ATXI) - Net Sales Margin|BCLI (BrainStorm Cell Therapeutics Inc.) - Net Sales Margin|Net Sales Margin Cara Therapeutics Inc|Net Margin Chromocell Therapeutics (CHRO)|Company Net Profitability ELYM|Net Margin Intra-Cellular ITCI|LBPH: Net Return on Sales|MRNS - Net Margin|NKGen Biotech, Inc. (NKGN) - Return on Sales by Net Profit|neurobopharma.com (NRBO) - Net Margin|SAGE: Company Net Profitability|Net Margin Synaptogenix, Inc.|Net Margin VIGL|Net Sales Margin WENA|Company Sales Margin Cerevel